In May, Representative Alexandria Ocasio Cortez confronted Gilead, the makers of PrEP, about the pill’s astronomical cost. "The list price is almost $2,000 in the United States. Why is it $8 in Australia?" the senator asked Gilead CEO Daniel O’Day before the House Committee on Oversight and Reform. “People are dying because of it, and there’s no enforceable reason for it.” (Gilead posted revenue of $3 billion off the once-a-day pill in 2018.)
— Permalink